GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY JR Brown; JA Woyach; K Patel; TA Eyre; Cy Cheah; P Ghia; W Jurczak; P Abada; WG Wierda; GFPN Presenter;

EXPERIÊNCIA INICIAL COM O PROTOCOLO HD21 (BRECADD) NO TRATAMENTO DO LINFOMA DE HODGKIN: DADOS DE VIDA REAL DE TRÊS CENTROS DE REFERÊNCIA BRASILEIROS GA Peruzini; JA Balthazar; MdL Garcia; BA Souza; BB Cal; NM Santana; LM Brandão; R Dalfeor; TTM Moura; AGO Braga; H Villefort; VdA Bovolenta; T Fischer; J Schimdt; TMB Silveira;

DISPARITIES IN ACCESS TO BIOLOGICAL MARKERS FOR NHL IN BRAZIL M Emmerick; R Dalfeor; F Zattar Piazera; T Fischer; AC Lopes; T Vanelli; CS Chiattone;